Philip Hewlett

Philip Hewlett is a Development Scientist I at Revvity, focusing on the development of diagnostic tests for infectious diseases since November 2024. Previously, Philip served as an Applications Scientist at Refeyn, where product development and customer application support were key responsibilities. Philip has a solid research background, having progressed from Research Associate to Senior Research Associate at Evox Therapeutics Ltd, concentrating on extracellular vesicle analytics. Philip's academic journey culminated in an Mbio in Biomedical Sciences from the University of Warwick, during which various research projects were undertaken, including studies on Cystic Fibrosis and Mycobacterium. Prior professional experience includes customer service at The Midcounties Co-operative during A-levels and university studies.